A meta-analysis of controlled trials of anticoagulant therapies in patients with sepsis.
about
Danaparoid sodium inhibits systemic inflammation and prevents endotoxin-induced acute lung injury in ratsHuman recombinant activated protein C for severe sepsisHuman recombinant protein C for severe sepsis and septic shock in adult and paediatric patientsHuman recombinant activated protein C for severe sepsisHuman recombinant activated protein C for severe sepsisA meta-analysis of controlled trials of recombinant human activated protein C therapy in patients with sepsis.Inhibition of lipopolysaccharide-induced interferon regulatory factor 3 activation and protection from septic shock by hydroxystilbenes.Maternal malaria induces a procoagulant and antifibrinolytic state that is embryotoxic but responsive to anticoagulant therapy.Tissue factor, blood coagulation, and beyond: an overview.Coagulation, inflammation, and the risk of neonatal white matter damage.Antithrombin III in critically ill patients: systematic review with meta-analysis and trial sequential analysisNovel pharmacologic approaches to the management of sepsis: targeting the host inflammatory response.Role of lipopolysaccharide and cecal ligation and puncture on blood coagulation and inflammation in sensitive and resistant mice models.Efficacy and safety of anticoagulant therapy in three specific populations with sepsis: a meta-analysis of randomized controlled trials.Effects of combination therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation.Treatment of low molecular weight heparin inhibits systemic inflammation and prevents endotoxin-induced acute lung injury in rats.Management of disseminated intravascular coagulation: current insights on antithrombin and thrombomodulin treatments.
P2860
Q21092892-0C6E83EF-E64A-4E0A-A327-64094436FD11Q24201123-F439B4F9-1BE8-4990-A9FB-2E1BAF8539A2Q24202128-56F19440-445F-4B13-90D0-5BE5E73B3577Q24235181-49BFFF0E-0F0A-4DFC-A566-3BCE0B56BFA3Q24242859-FD73888C-B603-47C3-8608-2D3BFF8AC537Q24816510-9AB4E950-7E36-4CEF-8623-2434B2049814Q34130251-A0AC0A5B-BD48-4A5E-A4C7-85D1D4A26B30Q34162714-20D27FD2-71D4-41B6-8627-08CF036854F0Q35222618-7912B8A5-0590-411D-9DD2-7385550011AEQ35671058-3A8EECF9-DF55-4201-84EB-DCBD099C98B2Q37014014-373000FB-B368-48E8-8AD8-27F3851FDAE0Q37367885-656566D9-695D-4ED5-815C-F5FD3FE9D7D1Q38585956-0704E12E-FF03-4267-98B2-69CC2AA11815Q38670135-D82AEDF4-6D09-4857-B9D3-86F391E25D55Q43464051-03FB1E6B-DF2D-4531-8382-FDDAA263A020Q47188763-D94B5995-0C6F-4963-A429-6551FB1082DBQ48516198-7D3B5A4F-8402-408C-A491-F25C171BDD58
P2860
A meta-analysis of controlled trials of anticoagulant therapies in patients with sepsis.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
A meta-analysis of controlled trials of anticoagulant therapies in patients with sepsis.
@en
A meta-analysis of controlled trials of anticoagulant therapies in patients with sepsis.
@nl
type
label
A meta-analysis of controlled trials of anticoagulant therapies in patients with sepsis.
@en
A meta-analysis of controlled trials of anticoagulant therapies in patients with sepsis.
@nl
prefLabel
A meta-analysis of controlled trials of anticoagulant therapies in patients with sepsis.
@en
A meta-analysis of controlled trials of anticoagulant therapies in patients with sepsis.
@nl
P2093
P1433
P1476
A meta-analysis of controlled trials of anticoagulant therapies in patients with sepsis.
@en
P2093
Barbara A Zehnbauer
Bradley D Freeman
Timothy G Buchman
P356
10.1097/01.SHK.0000068327.26733.10
P577
2003-07-01T00:00:00Z